Once a booming consumer-health company, 23andMe has struggled as its ambitions to become a leading healthcare company by building out the company's core product of tracking individual genetic ...

Rather than looking for one type of pathogen at a time, mNGS analyzes all the nucleic acids, RNA and DNA, that are present in ...

After a data breach affected around half of its customers, family ancestry company 23andMe has agreed to a $30 million settlement — and users could be eligible to receive a payout in the future.

Welcome to the cybernormal dystopia, nothing punk about it. "Insurers are refusing to cover Americans whose DNA reveals ...

(NYSE: BFLY), a digital health company transforming care through the power of portable ... cancer and found that using both RNA- and DNA-based sequencing methods together helped detect more actionable ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.

Nateratm is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the ...

Explore how the genetic testing industry is transforming healthcare through precision medicine ensuring patient privacy and ...

A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism in the h ...

Rather than looking for single types of pathogen one by one, the test analyzes all RNA and DNA that are present in a sample, ...

Researchers developed CpGPT, a novel foundation model for DNA methylation analysis that captures sequence, positional, and ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.